Press Releases

ProBioGen's GlymaxX® Technology reaches Phase III Clinical Development
read more ProBioGen's GlymaxX® Technology reaches Phase III Clinical Development
ProBioGen's GlymaxX® Technology made it again into Clinical Phase I
read more ProBioGen's GlymaxX® Technology made it again into Clinical Phase I

ProBioGen’s DirectedLuck™ Transposase Licensed by TOP15 Global BioPharma Company
read more ProBioGen’s DirectedLuck™ Transposase Licensed by TOP15 Global BioPharma Company